A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma
Clinical trial NCT04061772 · UNKNOWN
Trial details
- NCT number
- NCT04061772
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-12
- Primary completion
- 2021-07-05
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.